Techniques in Vascular & Interventional Radiology
Volume 9, Issue 2 , Pages 77-79 , June 2006

Pharmacologic Agents in Shock

  • Sue E. Hanks, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Sue E. Hanks, MD, Associate Professor of Clinical Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90007.

References 

  1. Holmes CL, Walley KR. The evaluation and management of shock. Clin Chest Med. 2003;24(4):775–789
  2. Orlinsky M, Shoemaker W, Reis ED, et al. Current controversies in shock and resuscitation. Surg Clin North Am. 2001;81(6):1217–1262
  3. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med. 1999;131(1):47–59
  4. Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest. 2002;121(3):877–905
  5. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345(8):588–595
  6. Brunton L, Lazo J, Parker K. Goodman and Gilman’s Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Professional; 2005;
  7. AMA Drug Evaluations. Chicago, IL: American Medical Association; 1995;
  8. Nasraway SA. Norepinephrine: no more “leave ’em dead”?. Crit Care Med. 2000;28(8):3096–3098
  9. Alderson P, Schierhout G, Roberts I, et al. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2000;2:CD000567
  10. Rhee P, Koustava E, Alam HB. Searching for the optimal resuscitation method: recommendation for the initial fluid resuscitation of combat casualties. J Trauma. 2003;54(suppl):52–62

PII: S1089-2516(06)00045-X

doi: 10.1053/j.tvir.2006.12.001

Techniques in Vascular & Interventional Radiology
Volume 9, Issue 2 , Pages 77-79 , June 2006

Article Tools